{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:52:03Z","timestamp":1791431523854,"version":"4.3.3"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100021096","name":"George Institute for Global Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jval.2025.08.014","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T23:28:56Z","timestamp":1756855736000},"page":"23-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methodological Insights From Health Valuation Studies in Low- and Middle-Income Countries: A Scoping Review"],"prefix":"10.1016","volume":"29","author":[{"given":"Thomas","family":"Gadsden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Verstraete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Carries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nokwanda","family":"Sithole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Lee","family":"Davids","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donela","family":"Besada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Angell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshini","family":"Govindasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2025.08.014_bib1","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"issue":"1","key":"10.1016\/j.jval.2025.08.014_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12962-021-00293-5","article-title":"Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis","volume":"19","author":"Hollingworth","year":"2021","journal-title":"Cost Eff Resour Alloc"},{"issue":"2","key":"10.1016\/j.jval.2025.08.014_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/20477724.2022.2106108","article-title":"How least developed to lower-middle-income countries use health technology assessment: a scoping review","volume":"117","author":"Falkowski","year":"2023","journal-title":"Pathog Glob Health"},{"issue":"3","key":"10.1016\/j.jval.2025.08.014_bib4","article-title":"Factors influencing the institutionalization of health technology assessment: a scoping literature review","volume":"9","author":"Mbau","year":"2023","journal-title":"Health Syst Reform"},{"key":"10.1016\/j.jval.2025.08.014_bib5","series-title":"Measuring and Valuing Health Benefits for Economic Evaluation","author":"Brazier","year":"2017"},{"issue":"1","key":"10.1016\/j.jval.2025.08.014_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jval.2018.05.010","article-title":"Overview, update, and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol","volume":"22","author":"Stolk","year":"2019","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2025.08.014_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference-based measure of health from the SF-36","volume":"21","author":"Brazier","year":"2002","journal-title":"J Health Econ"},{"issue":"10","key":"10.1016\/j.jval.2025.08.014_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40273-016-0404-1","article-title":"EuroQol protocols for time trade-off valuation of health outcomes","volume":"34","author":"Oppe","year":"2016","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jval.2025.08.014_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta5050","article-title":"Eliciting public preferences for healthcare: a systematic review of techniques","volume":"5","author":"Ryan","year":"2001","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.jval.2025.08.014_bib10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jval.2013.05.006","article-title":"Health state valuation in low- and middle-income countries: a systematic review of the literature","volume":"16","author":"Kularatna","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2025.08.014_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vhri.2023.07.004","article-title":"Estimation of societal values of health states preferences at the national level for low- and middle-income countries","volume":"39","author":"Espinosa","year":"2024","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.jval.2025.08.014_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/13696998.2022.2066441","article-title":"Methodological similarities and variations among EQ-5D-5L value set studies: a systematic review","volume":"25","author":"Poudel","year":"2022","journal-title":"J Med Econ"},{"issue":"9","key":"10.1016\/j.jval.2025.08.014_bib13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40273-022-01159-1","article-title":"A systematic review of the methodologies and modelling approaches used to generate international EQ-5D-5L value sets","volume":"40","author":"Rowen","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.jval.2025.08.014_bib14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2025.08.014_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vhri.2017.01.001","article-title":"Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L value sets","volume":"12","author":"Kularatna","year":"2017","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.jval.2025.08.014_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0272989X13480852","article-title":"Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist","volume":"34","author":"Xie","year":"2014","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2025.08.014_bib18","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jval.2025.08.014_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.15446\/rsap.v19n3.54226","article-title":"Calidad de vida relacionada con salud en la poblaci\u00f3n Colombiana:\u00bf c\u00f3mo valoran los colombianos su estado de salud? [Quality of life related to health in the Colombian population: how do Colombians perceive their health condition?]","volume":"19","author":"Rojas-Reyes","year":"2017","journal-title":"Rev Salud Publica (Bogota)"},{"key":"10.1016\/j.jval.2025.08.014_bib20","series-title":"Resultados de la Encuesta de Valoraci\u00f3n Social de los Estados de Salud Del EQ-5D En La Poblaci\u00f3n ecuatoriana (Results of the EQ-5D Social Assessment Survey of Health Status in the Ecuadorian Population)","author":"Flores Pr\u00f3cel","year":"2019"},{"issue":"suppl 2","key":"10.1016\/j.jval.2025.08.014_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40273-022-01210-1","article-title":"Estimating an EQ-5D-Y-3L value set for Indonesia by mapping the DCE onto TTO values","volume":"40","author":"Fitriana","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"suppl 2","key":"10.1016\/j.jval.2025.08.014_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40273-022-01216-9","article-title":"Estimating an EQ-5D-Y-3L value set for China","volume":"40","author":"Yang","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"10.1016\/j.jval.2025.08.014_bib23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s40273-024-01404-9","article-title":"Estimating an EQ-5D-Y-3L Value Set for Brazil","volume":"42","author":"Espirito Santo","year":"2024","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2025.08.014_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11136-018-2032-z","article-title":"Scoring the Child Health Utility 9D instrument: estimation of a Chinese child and adolescent-specific tariff","volume":"28","author":"Chen","year":"2019","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.jval.2025.08.014_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.vhri.2013.01.009","article-title":"Societal preferences for EQ-5D health states from a Brazilian population survey","volume":"2","author":"Viegas Andrade","year":"2013","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.jval.2025.08.014_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vhri.2019.08.475","article-title":"Valuing health state: an EQ-5D-5L value set for Ethiopians","volume":"22","author":"Welie","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"3","key":"10.1016\/j.jval.2025.08.014_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40273-021-01101-x","article-title":"Developing the EQ-5D-5L value set for Uganda using the \u2018Lite\u2019 protocol","volume":"40","author":"Yang","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.jval.2025.08.014_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10198-023-01635-1","article-title":"Valuation of EQ-5D-5L health states from cancer patients\u2019 perspective: a feasibility study","volume":"25","author":"Chai","year":"2024","journal-title":"Eur J Health Econ"},{"issue":"7","key":"10.1016\/j.jval.2025.08.014_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/OPX.0000000000000299","article-title":"Utility values among myopic patients in mainland China","volume":"91","author":"Li","year":"2014","journal-title":"Optom Vis Sci"},{"issue":"8","key":"10.1016\/j.jval.2025.08.014_bib30","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11136-023-03394-1","article-title":"Urban\/rural differences in preferences for EQ-5D-5L health states: a study of a multi-ethnic region in China","volume":"32","author":"Liao","year":"2023","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jval.2025.08.014_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12955-022-01917-x","article-title":"Rural population\u2019s preferences matter: a value set for the EQ-5D-3L health states for China\u2019s rural population","volume":"20","author":"Liu","year":"2022","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"10.1016\/j.jval.2025.08.014_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jval.2014.05.007","article-title":"Chinese time trade-off values for EQ-5D health states","volume":"17","author":"Liu","year":"2014","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2025.08.014_bib33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","article-title":"Estimating an EQ-5D-5L value set for China","volume":"20","author":"Luo","year":"2017","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2025.08.014_bib34","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s11136-020-02469-7","article-title":"An EQ-5D-5L value set for Vietnam","volume":"29","author":"Mai","year":"2020","journal-title":"Qual Life Res"},{"issue":"9","key":"10.1016\/j.jval.2025.08.014_bib35","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s11136-022-03143-w","article-title":"Estimating the EQ-5D-5L value set for the Philippines","volume":"31","author":"Miguel","year":"2022","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.jval.2025.08.014_bib36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14737167.2018.1494574","article-title":"The EQ-5D-5L Valuation study in Thailand","volume":"18","author":"Pattanaphesaj","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"10.1016\/j.jval.2025.08.014_bib37","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40273-017-0538-9","article-title":"The Indonesian EQ-5D-5L value set","volume":"35","author":"Purba","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jval.2025.08.014_bib38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40273-018-0758-7","article-title":"EQ-5D-5L Valuation for the Malaysian Population","volume":"37","author":"Shafie","year":"2019","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.jval.2025.08.014_bib39","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jval.2011.06.005","article-title":"Estimating population-based values for EQ-5D health states in Thailand","volume":"14","author":"Tongsiri","year":"2011","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2025.08.014_bib40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40273-020-00997-1","article-title":"Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension","volume":"39","author":"Wu","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"1 suppl","key":"10.1016\/j.jval.2025.08.014_bib41","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jval.2011.11.024","article-title":"Estimating an EQ-5D value set for Malaysia using time trade-off and visual analog scale methods","volume":"15","author":"Yusof","year":"2012","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.08.014_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12955-023-02180-4","article-title":"Valuing Chinese medicine quality of life-11 dimensions (CQ-11D) health states using a discrete choice experiment with survival duration (DCETTO)","volume":"21","author":"Zhu","year":"2023","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"10.1016\/j.jval.2025.08.014_bib43","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jval.2018.04.1370","article-title":"Time trade-off value set for EQ-5D-3L based on a nationally representative Chinese population survey","volume":"21","author":"Zhuo","year":"2018","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2025.08.014_bib44","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s11136-023-03378-1","article-title":"A national survey of Iranian general population to estimate a value set for the EQ-5D-5L","volume":"32","author":"Afshari","year":"2023","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.jval.2025.08.014_bib45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10198-024-01712-z","article-title":"Valuation of the EQ-5D-3L in Jordan","volume":"26","author":"Al Rabayah","year":"2025","journal-title":"Eur J Health Econ"},{"issue":"4","key":"10.1016\/j.jval.2025.08.014_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40273-021-01100-y","article-title":"The EQ-5D-5L valuation study in Egypt","volume":"40","author":"Al Shabasy","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jval.2025.08.014_bib47","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s11136-020-02730-z","article-title":"Valuing health-related quality of life using a hybrid approach: Tunisian value set for the EQ-5D-3L","volume":"30","author":"Chemli","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2025.08.014_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.vhri.2019.01.007","article-title":"Valuation of quality weights for EuroQol 5-dimensional health states with the time trade-off method in the capital of Iran","volume":"18","author":"Goudarzi","year":"2019","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.jval.2025.08.014_bib49","article-title":"Estimating the SF-6Dv1 value set for a population-based sample in Lebanon","volume":"42","author":"Kharroubi","year":"2024","journal-title":"Value Health Reg Issues"},{"issue":"3","key":"10.1016\/j.jval.2025.08.014_bib50","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3390\/ijerph17031037","article-title":"Examining the feasibility and acceptability of valuing the Arabic version of SF-6D in a Lebanese population","volume":"17","author":"Kharroubi","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"10.1016\/j.jval.2025.08.014_bib51","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jval.2020.05.004","article-title":"Peruvian valuation of the EQ-5D-5L: a direct comparison of time trade-off and discrete choice experiments","volume":"23","author":"Augustovski","year":"2020","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2025.08.014_bib52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1524-4733.2008.00468.x","article-title":"Argentine valuation of the EQ-5D health states","volume":"12","author":"Augustovski","year":"2009","journal-title":"Value Health"},{"issue":"5 suppl 1","key":"10.1016\/j.jval.2025.08.014_bib53","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.jval.2011.05.012","article-title":"Estimating the SF-6D value set for a population-based sample of Brazilians","volume":"14","author":"Cruz","year":"2011","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.jval.2025.08.014_bib54","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s40258-021-00658-0","article-title":"EQ-5D-5L health-state values for the Mexican population","volume":"19","author":"Gutierrez-Delgado","year":"2021","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"10.1016\/j.jval.2025.08.014_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0272989X15613521","article-title":"Brazilian valuation of EQ-5D-3L health states: results from a saturation study","volume":"36","author":"Santos","year":"2016","journal-title":"Med Decis Making"},{"issue":"7","key":"10.1016\/j.jval.2025.08.014_bib56","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jval.2021.11.1370","article-title":"Development of an EQ-5D value set for India using an extended design (DEVINE) study: the Indian 5-level version EQ-5D value set","volume":"25","author":"Jyani","year":"2022","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2025.08.014_bib57","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s11136-014-0906-2","article-title":"Valuing EQ-5D health states for Sri Lanka","volume":"24","author":"Kularatna","year":"2015","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.jval.2025.08.014_bib58","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s41669-023-00437-8","article-title":"The EQ-5D-3L valuation study in Pakistan","volume":"7","author":"Malik","year":"2023","journal-title":"Pharmacoecon Open"},{"issue":"3","key":"10.1016\/j.jval.2025.08.014_bib59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0272989X14559274","article-title":"Development of an EORTC-8D utility algorithm for Sri Lanka","volume":"35","author":"Kularatna","year":"2015","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2025.08.014_bib60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.vhri.2021.10.003","article-title":"A pilot study of valuation methods of the EQ-5D and the impact of literacy, cultural, and religious factors on preferences","volume":"30","author":"Malik","year":"2022","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.jval.2025.08.014_bib61","article-title":"An EQ-5D-5L value set for Ghana using an adapted EuroQol valuation technology protocol","volume":"45","author":"Addo","year":"2025","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.jval.2025.08.014_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-7954-1-11","article-title":"How do Zimbabweans value health states?","volume":"1","author":"Jelsma","year":"2003","journal-title":"Popul Health Metr"},{"issue":"5","key":"10.1016\/j.jval.2025.08.014_bib63","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","article-title":"Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets","volume":"15","author":"van Hout","year":"2012","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2025.08.014_bib64","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40258-025-00954-z","article-title":"A head-on comparison of EQ-VT- and crosswalk-based EQ-5D-5L value sets","volume":"23","author":"Bailey","year":"2025","journal-title":"Appl Health Econ Health Policy"},{"issue":"8","key":"10.1016\/j.jval.2025.08.014_bib65","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s10198-022-01539-6","article-title":"To what extent does the use of crosswalks instead of EQ-5D value sets impact reimbursement decisions?: a simulation study","volume":"24","author":"Ben","year":"2023","journal-title":"Eur J Health Econ"},{"issue":"5","key":"10.1016\/j.jval.2025.08.014_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40271-020-00490-z","article-title":"Time for tele-TTO? Lessons learned from digital interviewer-assisted time trade-off data collection","volume":"14","author":"Lipman","year":"2021","journal-title":"Patient"},{"issue":"6","key":"10.1016\/j.jval.2025.08.014_bib67","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jval.2024.02.020","article-title":"A methodological study to compare alternative modes of administration with value EQ-5D using preference-elicitation techniques","volume":"27","author":"Hill","year":"2024","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2025.08.014_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114519","article-title":"An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration","volume":"292","author":"Finch","year":"2022","journal-title":"Soc Sci Med"},{"issue":"4","key":"10.1016\/j.jval.2025.08.014_bib69","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jval.2025.01.003","article-title":"A value set for EQ-5D-5L in the United Arab Emirates","volume":"28","author":"Al Sayah","year":"2025","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2025.08.014_bib70","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jval.2018.01.016","article-title":"Advocating a paradigm shift in health-state valuations: the estimation of time-preference corrected QALY tariffs","volume":"21","author":"Jonker","year":"2018","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.jval.2025.08.014_bib71","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jval.2024.05.016","article-title":"A direct comparison between discrete choice with duration and composite time trade-off methods: do they produce similar results?","volume":"27","author":"Roudijk","year":"2024","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2025.08.014_bib72","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jval.2023.12.009","article-title":"Using the online elicitation of personal utility functions approach to derive a patient-based 5-level version of EQ-5D value set: a study in 122 patients with rheumatic diseases from Germany","volume":"27","author":"Schneider","year":"2024","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2025.08.014_bib73","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s11136-025-03989-w","article-title":"How well do participants understand the questions asked in the Online Personal Utility Functions (OPUF) approach? A cognitive debrief of the EQ-HWB-S (EQ Health and Wellbeing Short version) valuation","volume":"34","author":"Peasgood","year":"2025","journal-title":"Qual Life Res"},{"issue":"10","key":"10.1016\/j.jval.2025.08.014_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-077256","article-title":"Child health valuation protocol for a discrete choice experiment comparing paired comparison and kaizen tasks and estimating US EQ-5D-Y-3L values on an experience scale","volume":"13","author":"Jumamyradov","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jval.2025.08.014_bib75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vhri.2021.02.001","article-title":"Comparison of EQ-5D values sets among South American countries","volume":"26","author":"Tejada","year":"2021","journal-title":"Value Health Reg Issues"},{"issue":"7","key":"10.1016\/j.jval.2025.08.014_bib76","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s11136-021-03075-x","article-title":"Do health preferences differ among Asian populations? A comparison of EQ-5D-5L discrete choice experiments data from 11 Asian studies","volume":"31","author":"Yang","year":"2022","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2025.08.014_bib77","series-title":"Value sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide","first-page":"235","article-title":"How do EQ-5D-5L value sets differ?","author":"Roudijk","year":"2022"},{"issue":"3","key":"10.1016\/j.jval.2025.08.014_bib78","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10198-003-0182-5","article-title":"A single European currency for EQ-5D health states. Results from a six-country study","volume":"4","author":"Greiner","year":"2003","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2025.08.014_bib79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12874-022-01830-3","article-title":"In search of a \u2018pan-European value set\u2019; application for EQ-5D-3L","volume":"23","author":"Sajjad","year":"2023","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"10.1016\/j.jval.2025.08.014_bib80","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40273-025-01483-2","article-title":"The use of EQ-5D in the Middle East and North Africa region: a systematic literature review","volume":"43","author":"Al Rabayah","year":"2025","journal-title":"Pharmacoeconomics"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525025306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525025306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:11:26Z","timestamp":1791429086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525025306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1098301525025306"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.08.014","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methodological Insights From Health Valuation Studies in Low- and Middle-Income Countries: A Scoping Review","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}